Tatva Chintan Pharma Chem Limited has fixed Friday, September 11, 2026 as the record date to determine eligibility for its proposed final dividend of ₹2 per equity share for FY26. The company will hold its 30th Annual General Meeting on September 25, 2026.

The filing, dated August 27, 2026, complies with Regulation 42 and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders on the register as of the record date will be entitled to the dividend if approved by members at the AGM. Payout is scheduled for on or after October 1, 2026.

Book Closure and Voting Details

The Register of Members and Share Transfer Books will remain closed from Saturday, September 12, 2026 to Friday, September 25, 2026 (both days inclusive). This closure facilitates the AGM proceedings and dividend entitlement verification.

Pursuant to Section 108 of the Companies Act, 2013, the company has set Friday, September 18, 2026 as the cut-off date for shareholders to exercise their right to vote electronically. Remote e-voting will be open from September 22, 2026 at 9:00 am to September 24, 2026 at 5:00 pm.

Financial Performance FY26

The AGM agenda includes the adoption of audited standalone and consolidated financial statements for FY26. The company reported revenue from operations of ₹4,962.96 million. EBITDA, including other income, stood at ₹928.58 million, while profit after tax was reported at ₹390.82 million.

Director Re-appointments

Shareholders will vote on the re-appointment of three key directors for a three-year term commencing February 1, 2027:

• Mr. Chintan Nitinkumar Shah as Managing Director
• Mr. Ajaykumar Mansukhlal Patel as Whole-time Director
• Mr. Shekhar Rasiklal Somani as Whole-time Director

The proposed annual fixed gross remuneration for each director is ₹15,994,788, comprising basic salary and allowances. This amount is lower than the remuneration paid in FY26, which was ₹16,503,252 plus provident fund contributions for each director.

Borrowing Limits and Charges

The Board seeks shareholder approval to increase the maximum borrowing limit to ₹1,000 crore under Section 180(1)(c) of the Companies Act, 2013. Additionally, members will vote on creating charges on company assets up to the same limit to secure borrowings or third-party obligations.

AGM Logistics

The 30th AGM will be held on Friday, September 25, 2026, at 4:00 pm via Video Conferencing or Other Audio Visual Means. The annual report is available on the company's website at www.tatvachintan.com . Shareholders who have not registered their email addresses will receive a letter containing a web-link and QR code to access the document.

Tatva Chintan Pharma Chem Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The filing discloses a standalone turnover of ₹4,962.96 million and a net worth of ₹7,582.29 million.

The company operates in the specialty chemicals sector, with exports contributing 75% of its total turnover. Its primary business activities include the manufacturing of Structure Directing Agents, Phase Transfer Catalysts, and Pharmaceutical and Agrochemical Intermediates.

Business Performance and Operations

The entity reported its financial position based on standalone figures. The paid-up capital stands at ₹233.92 million. The company maintains two manufacturing plants and two offices within India, serving customers across 17 states domestically and 30 countries internationally.

Environmental Metrics

The report details significant environmental data points for FY26 compared to the previous year. Total energy consumption from non-renewable sources rose to 285,897.23 Gigajoules, up from 206,466.60 Gigajoules in FY25. This increase coincided with a rise in Scope 1 greenhouse gas emissions to 10,637.93 t CO₂ eq. from 7,661.79 t CO₂ eq.

Water withdrawal increased to 122,859 kiloliters, entirely sourced from third parties, compared to 83,554 kiloliters in the prior year. The Ankleshwar manufacturing unit continues to operate as a Zero Liquid Discharge facility since January 2020.

Social and Governance Disclosures

The company employs 363 permanent employees and 734 workers. The workforce is predominantly male, with women constituting 6.06% of permanent employees and 0.27% of workers. The turnover rate for permanent employees was 49.79% in FY26, an increase from 30.06% in FY25.

No complaints were received regarding sexual harassment, child labor, or forced labor during the reporting period. The company reported 14 customer complaints, all of which were resolved by the end of the year. There were no instances of fines or penalties paid to regulators or law enforcement agencies.

What the Numbers Show

The divergence between rising operational inputs and stable efficiency metrics warrants attention. While total energy consumption jumped significantly to 285,897.23 GJ from 206,466.60 GJ, the energy intensity per rupee of turnover remained nearly flat, moving from 0.0000563 to 0.0000576. This suggests that the substantial increase in absolute energy usage was largely absorbed by proportional growth in production volume or revenue, rather than indicating a decline in operational efficiency.